The United States Postal Service has unveiled that its new Black Heritage stamp will be of Phillis Wheatley, who is believed to be the first African American author to publish a book of poetry.

The U.S. Postal Service will honor Phillis Wheatley—the first author of African descent in the American colonies to publish a book—with the 49th stamp in its Black Heritage series, celebrating her ...

It is safe to say that the Tennessee football program will look a bit different when spring ball rolls around in a few months. The coaching staff will have a slightly new look as well, with the most ...

Several new stamps will be available next year, along with dedication ceremonies for a select few. The United States Postal Service (USPS) announced 19 stamp designs to be unveiled in 2026 back in ...

Times Watchdog stories dig deep to hold power accountable, right wrongs and create change. This work is made possible by The Seattle Times Investigative Journalism Fund. Donate today to support ...

Back in May 2025, Jacob Harris was half-asleep in bed at his East Vancouver home when a big idea hit him. Earlier in the week, his partner Karoline Moore had brought home lino printing supplies from a ...

Matt Katz (left) and Jake Welty (right) reveal the one-of-one Vector M12 racecar. Video by Drew Manley (Cooled Collective) In a nondescript storage facility on the outskirts of Los Angeles, a small ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Boston Urban Hospitality owner ...

There have been too many disappointments to count for the Miami Dolphins so far in the 2025 season, but one that has flown the radar a bit — and really shouldn't — has been the performance of edge ...

A collaboration between the Children’s Hospital of Philadelphia and Penn Medicine has been awarded a National Institutes of Health grant as part of a broader $50 million effort to fund 13 autism ...

In the POLARIX study (ClinicalTrials.gov identifier: NCT03274492), polatuzumab vedotin plus rituximab, cyclophosphamide, doxorubicin, and prednisone (Pola-R-CHP) showed a significant progression-free ...